K Syrjänen Selected Research

Messenger RNA (mRNA)

6/2000

Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Syrjänen Research Topics

Disease

18	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2010 - 05/2000
14	Neoplasms (Cancer) 03/2010 - 02/2000
8	Uterine Cervical Dysplasia 02/2007 - 05/2000
6	Colorectal Neoplasms (Colorectal Cancer) 07/2009 - 01/2006
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2006 - 02/2000
6	Carcinoma (Carcinomatosis) 11/2001 - 02/2000
4	Papillomavirus Infections 02/2015 - 06/2003
4	Neoplasm Metastasis (Metastasis) 01/2008 - 03/2006
3	Rectal Neoplasms (Rectal Cancer) 01/2011 - 03/2009
3	Infections 01/2011 - 07/2000
3	Carcinogenesis 01/2008 - 01/2006
2	Disease Progression 01/2004 - 06/2003
2	Ovarian Epithelial Carcinoma 10/2001 - 06/2000
1	Hypoxia (Hypoxemia) 03/2010
1	Fatigue 07/2009
1	Aneuploidy (Aneuploid) 01/2009
1	Substance-Related Disorders (Drug Abuse) 01/2008
1	Microsatellite Instability 01/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2004
1	Esophageal Squamous Cell Carcinoma 11/2001
1	Endometriosis 10/2001
1	Residual Neoplasm 10/2001
1	Epstein-Barr Virus Infections 09/2000
1	Carcinoma in Situ 07/2000
1	Ovarian Neoplasms (Ovarian Cancer) 06/2000
1	Margins of Excision 02/2000
1	Esophageal Neoplasms (Esophageal Cancer) 02/2000

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 02/2015 - 02/2000
4	Proteins (Proteins, Gene)FDA Link 03/2010 - 06/2000
3	Acetic Acid (Vinegar)FDA LinkGeneric 09/2005 - 01/2001
2	Biomarkers (Surrogate Marker)IBA 06/2011 - 01/2011
2	Fluorouracil (Carac)FDA LinkGeneric 01/2008 - 01/2007
2	Oncogene Proteins (Oncogene Protein)IBA 02/2007 - 11/2006
2	Biological ProductsIBA 10/2006 - 10/2001
2	Lugol's solution (Lugol's iodine)IBA 09/2005 - 01/2005
2	Indicators and Reagents (Reagents)IBA 11/2001 - 01/2001
2	Transcription Factors (Transcription Factor)IBA 07/2000 - 06/2000
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	VaccinesIBA 12/2010
1	Group II Phospholipases A2IBA 07/2009
1	IsoenzymesIBA 03/2009
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2009
1	Carbonic Anhydrase IXIBA 03/2009
1	Thymidylate SynthaseIBA 01/2008
1	beta CateninIBA 01/2008
1	Cell Adhesion MoleculesIBA 01/2008
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2007
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2006
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2006
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2006
1	Nucleoside-Diphosphate KinaseIBA 10/2006
1	trioctyl phosphine oxide (TOPO)IBA 10/2006
1	NF-kappa B (NF-kB)IBA 08/2006
1	Hormones (Hormone)IBA 05/2006
1	Tissue Inhibitor of Metalloproteinase-2IBA 03/2006
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2006
1	Matrix Metalloproteinases (MMPs)IBA 03/2006
1	Cadherins (E-Cadherin)IBA 01/2006
1	Vascular Endothelial Growth Factor CIBA 01/2006
1	Cyclin DIBA 10/2004
1	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2004
1	AntibodiesIBA 11/2001
1	Keratins (Keratin)IBA 11/2001
1	Protein Isoforms (Isoforms)IBA 01/2001
1	Etoposide (VP 16)FDA LinkGeneric 01/2001
1	Cisplatin (Platino)FDA LinkGeneric 01/2001
1	IodineIBA 01/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2001
1	SolutionsIBA 01/2001
1	Epirubicin (Ellence)FDA LinkGeneric 01/2001
1	NucleotidesIBA 07/2000
1	Messenger RNA (mRNA)IBA 06/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2000
1	A-Form DNA (A-DNA)IBA 06/2000
1	Transcription Factor AP-2IBA 06/2000
1	HPV DNA ProbesIBA 02/2000

Therapy/Procedure

5	Aftercare (After-Treatment) 11/2006 - 10/2004
3	Chemoradiotherapy 01/2011 - 03/2009
2	Radiotherapy 01/2011 - 03/2010
2	Palliative Care (Palliative Therapy) 07/2009 - 01/2008
2	Contraception (Birth Control) 01/2008 - 01/2004
2	Highly Active Antiretroviral Therapy (HAART) 01/2004 - 06/2003
2	Neoadjuvant Therapy 11/2001 - 01/2001
2	Therapeutics 11/2001 - 10/2001
1	Hormonal Contraception 01/2008
1	Drug Therapy (Chemotherapy) 01/2007
1	Hysterectomy 01/2001